Status: current, Sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2018. Module: SNOMED CT core
Descriptions:
| Id | Description | Lang | Type | Status | Case? | Module |
| 3523390012 | Product containing gemtuzumab ozogamicin (medicinal product) | en | Fully specified name | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| 3715003013 | Gemtuzumab ozogamicin-containing product | en | Synonym (core metadata concept) | Active | Entire term case insensitive (core metadata concept) | SNOMED CT core |
| Outbound Relationships | Type | Target | Active | Characteristic | Refinability | Group | Values |
| Product containing gemtuzumab ozogamicin (medicinal product) | Is a | Product containing monoclonal antibody (product) | false | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Is a | Antineoplastic agent | false | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Has active ingredient | Gemtuzumab ozogamicin | true | Inferred relationship | Some | 1 | |
| Product containing gemtuzumab ozogamicin (medicinal product) | Has active ingredient | Immunosuppressant (substance) | false | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Has active ingredient | Biological agent | false | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Has active ingredient | Antineoplastic agent (substance) | false | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Is a | Product containing immunomodulator (product) | true | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Plays role | Antineoplastic therapeutic role | true | Inferred relationship | Some | ||
| Product containing gemtuzumab ozogamicin (medicinal product) | Is a | Medicinal product containing monoclonal antibody and acting as antineoplastic agent (product) | true | Inferred relationship | Some |
| Inbound Relationships | Type | Active | Source | Characteristic | Refinability | Group |
| Product containing precisely gemtuzumab ozogamicin 5 milligram/1 vial powder for conventional release solution for injection (clinical drug) | Is a | False | Product containing gemtuzumab ozogamicin (medicinal product) | Inferred relationship | Some | |
| Product containing gemtuzumab ozogamicin in parenteral dose form (medicinal product form) | Is a | True | Product containing gemtuzumab ozogamicin (medicinal product) | Inferred relationship | Some | |
| Product containing only gemtuzumab ozogamicin (medicinal product) | Is a | True | Product containing gemtuzumab ozogamicin (medicinal product) | Inferred relationship | Some |
This concept is not in any reference sets
FHIR